Secura Bio Revenue and Competitors
Estimated Revenue & Valuation
- Secura Bio's estimated annual revenue is currently $4M per year.
- Secura Bio's estimated revenue per employee is $100,500
- Secura Bio's total funding is $90M.
Employee Data
- Secura Bio has 40 Employees.
- Secura Bio grew their employee count by 43% last year.
Secura Bio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | SVP Operations | Reveal Email/Phone |
2 | Controller | Reveal Email/Phone |
3 | HEAD OF CORPORATE DEVELOPMENT | Reveal Email/Phone |
4 | Head Medical Affairs - Europe | Reveal Email/Phone |
5 | Chief Legal Officer & General Counsel | Reveal Email/Phone |
6 | Director Global Training & Development | Reveal Email/Phone |
7 | Director Key Accounts | Reveal Email/Phone |
8 | Senior Regional Business Director | Reveal Email/Phone |
9 | Medical Science Liaison | Reveal Email/Phone |
10 | President & CEO | Reveal Email/Phone |
Secura Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Secura Bio?
Secura Bioￃﾢ￢ﾀﾞￂﾢ is a pharmaceutical company committed to giving patients access to innovative therapies.
keywords:N/A
$90M
Total Funding
40
Number of Employees
$4M
Revenue (est)
43%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Secura Bio News
In December, Secura Bio voluntarily withdrew the follicular lymphoma indication. Nicole Gormley, MD. Nicole Gormley. This degree of safety...
... Bayer's copanlisib, Secura Bio's develisib, and TG Therapeutics' Ukoniq (umbralisib), as well as the history of safety issues patients...
The FDA has approved four PI3K inhibitors for various blood cancers: Gilead Sciences' Zydelig, Bayer's Aliqopa, Secura Bio's Copiktra and TG...
LAS VEGAS, June 9, 2021 /PRNewswire/ -- Secura Bio, Inc. (Secura Bio) - (www.securabio.com), an integrated pharmaceutical company dedicated to the worldwide development and commercialization of impactful oncology therapies, today announced that on May 19, 2021 the European Medicines Agency gra ...
SUMMERLIN, Nev., April 8, 2021 /PRNewswire/ -- Secura Bio, Inc. (Secura Bio) - (www.securabio.com), an integrated pharmaceutical company dedicated to the worldwide development and commercialization of impactful oncology therapies, today announced that it has completed enrollment, with 101 pati ...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.6M | 40 | N/A | N/A |
#2 | $5.8M | 40 | N/A | N/A |
#3 | $3.3M | 40 | N/A | N/A |
#4 | $9.3M | 40 | N/A | N/A |
#5 | $4.6M | 40 | N/A | N/A |